Androgens and the control of lipid metabolism in human prostate cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 65, Issue 1-6, 1998, Pages 191-198

  Swinnen, Johannes V ^a   Verhoeven, Guido ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CHOLESTEROL ESTER; FATTY ACID BINDING PROTEIN; FATTY ACID SYNTHASE; METRIBOLONE; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DNA CONTENT; DOSE RESPONSE; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID METABOLISM; LIPOGENESIS; MALE; PROSTATE CANCER; TRANSCRIPTION REGULATION;

ANDROGENS; FATTY ACID SYNTHETASE COMPLEX; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPID METABOLISM; MALE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032053210     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00187-8     Document Type: Conference Paper

References (52)

1. Huggins C., Hodges C. V. Studies on prostatic cancer: Effect of castration, of estrogen, and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1:1941;293-297.
2. Horoszewicz J. S., Leong S., Kawinski E., Karr J. P., Rosenthal H., Chu T. M., Mirand E. A., Murphy G. P. LNCaP model of human prostatic carcinoma. Cancer Res. 43:1983;1809-1818.
3. Knudsen J., Mandrup S., Rasmussen J. T., Andreasen P. H., Poulsen F., Kristiansen K. The function of acyl-CoA-binding protein (ACBP)/diazepam binding inhibitor (DBI). Mol. Cell. Biochem. 123:1993;129-138.
4. Papadopoulos V., Brown A. S. Role of the peripheral-type benzodiazepine receptor and the polypeptide diazepam binding inhibitor in steroidogenesis. J. Steroid. Biochem. Mol. Biol. 53:1995;103-110.
5. Swinnen J. V., Esquenet M., Heyns W., Rombauts W., Verhoeven G. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcima cell line LNCaP. Mol. Cell. Endocrinol. 104:1994;153-162.
6. Swinnen J. V., Esquenet M., Rosseels J., Claessens F., Rombauts W., Heyns W., Verhoeven G. A human gene encoding diazepam-binding inhibitor/acyl-CoA-binding protein: Transcription and hormonal regulation in the androgen-sensitive human prostatic adenocarcinoma cell line LNCaP. DNA Cell Biol. 15:1996;97-208.
7. Swinnen J. V., Vercaeren I., Esquenet M., Heyns W., Verhoeven G. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the rat. Mol. Cell. Endocrinol. 118:1996;65-70.
8. Kuhajda F. P., Jenner K., Wood F. D., Hennigar R. A., Jacobs L. B., Dick J. D., Pasternack G. R. Fatty acid synthase: A potential selective target for antineoplastic therapy. Proc. Natl. Acad. Sci. USA. 91:1994;6379-6383.
9. Pizer E. S., Wood F. D., Pasternack G. R., Kuhajda F. P. Fatty acid synthase (FAS): A target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. Cancer Res. 56:1996;734-751.
10. Pizer E. S., Wood F. D., Heine H. S., Romantsev F. E., Pasternack G. R., Kuhajda F. P. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res. 56:1996;1189-1193.
11. Pizer E. S., Jackisch C., Wood F. D., Pasternack G. R., Davidson N. E., Kuhajda F. P. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Res. 56:1996;2745-2747.
12. Ramirez-Zacarias J. L., Castro-Munozledo F., Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry. 97:1992;493-497.
13. Swinnen J. V., Van Veldhoven P. P., Esquenet M., Heyns W., Verhoeven G. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP. Endocrinology. 137:1996;4468-4474.
14. Esquenet, M., Swinnen, J. V., Heyns, W. and Verhoeven, G., LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids. J. Steroid. Biochem. Mol. Biol., 62 (1997), 391-399.
15. Riegman P. H. J., Vlietstra R. J., van der Korput J. A. G. M., Brinkmann A. O., Trapman J. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol. Endocrinol. 5:1991;1921-1930.
16. Young C. Y.-F., Montgomery B. T., Andrews P. E., Qiu S., Bilhartz D. L., Tindall D. J. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res. 51:1991;3748-3752.
17. Henttu P., Liao S., Vihko P. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA) but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology. 130:1992;766-772.
18. Wolf D. A., Schulz P., Fittler F. Transcriptional regulation of prostate kallikrein-like genes by androgen. Mol. Endocrinol. 6:1992;753-762.
19. Cleutjens K. B. J. M., Vaneekelen C. C. E. M., Vanderkorput H. A. G. M., Brinkmann A. O., Trapman J. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate specific antigen promoter. J. Biol. Chem. 271:1996;6379-6388.
20. Braunstein H. Staining lipids in carcinoma of the prostate gland. Am. J. Clin. Pathol. 41:1964;44-48.
21. Fisher E. R., Jeffrey W. Ultrastructure of human normal and neoplastic prostate. Am. J. Clin. Pathol. 44:1965;119-134.
22. Mao P., Nakao K., Angrist A. Human prostatic carcinoma: An electron microscope study. Cancer Res. 26:1966;955-973.
23. Kuhajda F. P., Piantadosi S., Pasternack G. R. Haptoglobin-related epitopes in breast cancer as a predictor of recurrence of the disease. N. Engl. J. Med. 321:1989;636-641.
24. Corrigan C., Martin A. W., Lear S. C., Kuhns S., Kuhajda F. P., Pasternack G. R. Prognostic value of the immunohistochemical demonstration of haptoglobin-related protein in breast cancer. Am. J. Clin. Pathol. 96:1991;406.
25. Shurbaji M. S., Kuhajda F. P., Pasternack G. R., Thurmond T. S. Expression of oncogenic antigen 519 (OA-519) in prostate cancer is a potential prognostic indicator. Am. J. Clin Pathol. 97:1992;686-691.
26. Redston M. S., Kern S. E., Vogelstein B., Hamilton S. R. Expression of OA519 (haptoglobin-related protein epitopes) in colorectal carcinomas: Comparison with molecular genetic alterations and metastasis. Mod. Pathol. 5:1992;47A.
27. Jensen V., Holm-Nielsen P., Melsen F. OA-519 expression in node negative breast cancer. Breast Cancer Res. Treat. 27:1993;1-2.
28. Jensen V., Ladekari M., Holm-Nielsen P., Flemming B. S., Flemming M. The prognostic value of oncogenic antigen 519 (OA519) expression and proliferative activity detected by antibody MIB-1 in node negative breast cancer. J. Pathol. 176:1995;343-352.
29. Hardman W., Gansler T., Schaffel S., Henniger R. OA-519 immunostaining portends poor prognosis in ovarian cancer. Mod. Pathol. 8:1995;90A.
30. Epstein J. I., Carmichael M., Partin A. W. OA-519 (fatty acid synthase) as an independent predictor of pathologic stage in adenocarcinoma of the prostate. Urology. 45:1995;81-86.
31. Alo P. L., Visca P., Marci A., Mangoni A., Botti C., Di Tondo U. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer. 77:1996;474-482.
32. Bobrow L. G., Happerfield L. C., Pasternack G. R., Smith P., Owens A. H. The expression of fatty acid synthase in primary breast cancer: Is it an independent prognostic indicator? Breast Cancer Res. Treat. 27:1993;159.
33. Rashid A., Pizer E. S., Moga M., Milgraum L. Z., Zahurak M., Pasternack G. R., Kuhajda F. P., Hamilton S. R. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal cancer. Am. J. Pathol. 150:1997;201-208.
34. Pizer E. S., Wood F. D., Pasternack G. R., Kuhajda F. P. Altered fatty acid biosynthesis in endometrial carcinoma. Mod. Pathol. 8:1995;95A.
35. Chalbos D., Escot C., Joyeux C., Tissot-Carayon M.-J., Pages A., Rochefort H. Expression of the progestin-induced fatty acid synthase in benign mastopathies and breast cancer as measured by RNA in situ hybridization. J. Natl. Cancer Inst. 82:1990;602-606.
36. Swinnen J. V., Esquenet M., Goossens K., Heyns W., Verhoeven G. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res. 57:1997;1086-1090.
37. MacDougald O. A., Lane M. D. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64:1995;345-373.
38. Swinnen J. V., Ubrix W., Heyns W. and Verhoeven G., Coordinate regulation of lipogenic gene expression by androgens: Evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc. Natl. Acad. Sci. USA. 94 (1997) 12975-12980.
39. Briggs M. R., Yokoyama C., Wang X., Brown M. S., Goldstein J. L. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. J. Biol. Chem. 268:1993;14490-14496.
40. Shimano H., Horton J. D., Hammer R. E., Shimomura I., Brown M. S., Goldstein J. L. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J. Clin. Invest. 98:1996;1575-1584.
41. Yokoyama C., Wang X., Briggs M. R., Admon A., Wu J., Hua X., Goldstein J. L., Brown M. S. SREBP-1, a basic-helix-loop-helix leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 75:1993;187-197.
42. Vallett S. M., Sanchez H. B., Rosenfeld J. M., Osborne T. F. A direct role for sterol regulatory element binding protein in activation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene. J. Biol. Chem. 271:1996;12247-12253.
43. Jackson S. M., Ericsson J., Metherall J. E., Edwards P. A. Role for sterol regulatory element binding protein in the regulation of farnesyl diphosphate synthase and in the control of cellular levels of cholesterol and triglyceride: evidence from sterol regulation-defective cells. J. Lipid Res. 37:1996;1712-1721.
44. Ericsson J., Jackson S. M., Lee B. C., Edwards P. A. Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene. Proc. Natl. Acad. Sci. USA. 93:1996;945-950.
45. Guan G., Jiang G., Koch R. L., Shechter I. Molecular cloning and functional analysis of the promoter of the human squalene synthase gene. J. Biol. Chem. 270:1995;21958-21965.
46. Tontonoz P., Kim J. B., Graves R. A., Spiegelman B. M. ADD1: A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol. Cell. Biol. 13:1993;4753-4759.
47. Kim J. B., Spiegelman B. M. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes and Dev. 10:1996;1096-1107.
48. Lopez, J. M., Bennett, M. K., Sanchez, H. B., Rosenfeld, J. M. and Osborne, T. F., Sterol regulation of acetyl coenzyme A carboxylase: a mechanism for coordinate control of cellular lipid. Proc. Natl. Acad. Sci. USA, 93, (1996) 1049-1053.
49. Bennet M. K., Lopez J. M., Sanchez H. B., Osborne T. F. Sterol regulation of fatty acid synthase promoter: Coordinate feedback regulation of two major lipid pathways. J. Biol. Chem. 270:1995;25578-25583.
50. Sato R., Inoue J., Kawabe Y., Komada T., Takano T., Maeda M. Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein 2. J. Biol. Chem. 271:1996;26461-26464.
51. Chambon M., Rochefort H., Vial H., Chalbos D. Progestins and androgens stimulate lipid accumulation in T47D breast cancer cells via their own receptors. J. Steroid Biochem. 33:1989;915-922.
52. Bacus S. S., Kiguchi K., Chin D., King R., Huberman E. Differentiation of cultured human breast cancer cells (AU-565 and MCF-7) associated with loss of cell surface HER-2/neu antigen. Mol. Carcinogenesis. 3:1990;350-362.